Market open · Delayed intraday data · 12:26 PM ET

Last update: Jun 29, 2026, 12:01 PM ET

Eli Lilly and Company (LLY) — What Changed

$1,214.01+5.89 (+0.49%) today so far

Jun 29, 2026 12:26 PM ET·New York Stock Exchange·Market Open·CEO: David A. Ricks·47,000 employees

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a c…

🔔Major Change Detected

Market Cap

$1.1T

Sector

Healthcare

Drug Manufacturers - General

Next Earnings

Aug 4, 2026

(37 Days)

Relative Volume

0.56x

Below Avg

Risk Level

Low

Price Move

+0.49%

1-Day Change

Below 5D Avg: +-1.5%

Volume Confirmation

0.56x

vs 30D Average

Below Avg

Catalyst

Earnings Beat

Material / Earnings

Eli Lilly (LLY) rose 22.7% after reporting EPS of $8.55, beating consensus…

Peer Context

Outperforming

Top 1 of 6 peers

Company-Specific Move

Signal Quality

Low

Confidence Score

57/100

BestStocks surfaces only meaningful changes—backed by price, volume, catalysts, and peer context—so you can focus on what matters.

1Event Reaction Chartⓘ

Price reaction around a key event

LLYEli Lilly and Company$1,214.01+5.89 (+0.49%)

Price Move Up·Jun 26, 2026·+7.13% reaction

1. What Changed Since Last Close

Earnings BeatHighHigh

Apr 30

Eli Lilly (LLY) rose 22.7% after reporting EPS of $8.55, beating consensus estimates of $6.97 by 22.7%.

›

Earnings BeatHighHigh

Mar 31

Eli Lilly (LLY) reported quarterly EPS of $8.55, beating analyst consensus of $6.79 by 25.9%. The company delivered sign

›

Price Move UpHighHigh

Jun 26+7.13%1.92x vol

LLY surged 7.13% to $1,208.12, hitting an all-time high. The move is driven by expanded access to obesity drugs Foundayo

›

New FilingMediumMedium

May 20

Eli Lilly and Company (LLY) filed a new 8-K on 2026-05-20 with no associated price movement on the filing date.

›

NewsMediumMedium

undefined NaN

Medicare's new Bridge program begins covering obesity drugs like Lilly's Mounjaro with $50 monthly copays for seniors.

›

Showing 5 of 8 events

2. Change Timeline

Date	Change	Price Reaction	Volume	Confidence ↓
Apr 30	EEarnings Beat	—	—	High
Mar 31	EEarnings Beat	—	—	High
Jun 26	VPrice Move Up	+7.13%	1.92x	High
May 20	FNew Filing	—	—	Medium
undefined NaN	NNews	—	—	Medium
undefined NaN	NNews	—	—	Medium
Jun 29	VPrice Move Up	—	—	Low
Jun 25	VPrice Move Up	+0.93%	0.68x	Low

Sort:

3. Why It Moved

Primary Catalyst

Earnings Beat

Eli Lilly (LLY) rose 22.7% after reporting EPS of $8.55, beating consensus estim

Supporting Evidence

Eli Lilly (LLY) rose 22.7% after reporting EPS of $8.55, beating conse
Eli Lilly (LLY) reported quarterly EPS of $8.55, beating analyst conse
LLY surged 7.13% to $1,208.12, hitting an all-time high. The move is d
LLY rose 0.61% to $1215.50 intraday, hitting a new high alongside peer

Nature of Move

Company-Specific Move

LLY outperformed peers by more than expected sector variance — move appears company-specific.

4. Peer / Sector Confirmation

Symbol	Today	5D	Rel. Vol
LLY	+0.49%	—	0.56x	Leader
UNH	+2.97%	—	—
JNJ	+3.99%	—	—
PFE	+2.62%	—	—
ABBV	+4.20%	—	—
MRK	+2.56%	—	—

Company-Specific Move. Top 1 of 6 peers. LLY outperformed peers by more than expected sector variance — move appears company-specific.

5. SEC Filing Watch

8-K

May 20High

Material event — review for impact

8-K

May 7High

Material event — review for impact

10-Q

Apr 30Medium

Quarterly financial results

8-K

Apr 30High

Material event — review for impact

DEF 14A

Mar 20Low

Annual proxy — exec compensation & governance

View on SEC EDGAR →Source: filing_snapshots DB · past 120 days

6. Analyst Expectations

Consensus Target

$1,269.94

Median Target

$1,270.00

Upside to Target

+4.6%

vs $1214.01

Analyst Activity — Last 90 Days

Upgrades

Maintains

Downgrades

Last Directional Actions

↑ Upgrade

Freedom Broker · Hold → Buy

Feb 10, 2026

↓ Downgrade

HSBC · Hold → Reduce

Mar 17, 2026

View Analyst Detail →

7. Bull vs Bear Thesis Shift

Bullish Factors

✓Earnings beat with positive market reaction

✓Positive 0.5% session move

✓LLY surged 7.13% to $1,208.12, hitting an all-time high. The

✓Positive price momentum

✓Eli Lilly and Company (LLY) moved +0.93% from $1117.26 to $1

Bearish Factors

✕New SEC filing — review for material disclosures

Net Thesis Change vs Yesterday

BearishNeutralBullish

Bullish Shift+48 / 100

8. What To Watch Next

Date	Event	Impact
Jul 30est.	10-Q Filing	Medium
Aug 5	Earnings Release	High

est. = estimated from prior filing cycle

🔔

9. Set Alerts & Get Notified

Get notified when LLY reports earnings, files an 8-K, receives an analyst upgrade, or sees unusual volume.

✓ Earnings alerts

✓ Filing alerts

✓ Volume spikes

✓ Analyst actions